• A senior engineer at Google wrote a manifesto against diversity and employees are furious (GOOG, GOOGL)

    Google employees are up in arms after a senior engineer at the company penned an anti-diversity manifesto that has spread through the company like wildfire. 
    The manifesto apparently argued that Google should halt initiatives aimed at increasing gender and racial diversity within the company and instead focus on "ideological diversity," according to a report by Vice's Motherboard, which first reported the news late on Friday. The document also reportedly argued that biological differen
  • Traders are betting big on a stock market shock

    Volatility traders haven't been this sure of a stock market shock in almost two years.
    These investors buy and sell options on the CBOE Volatility Index, or VIX, as they predict swings (or a lack thereof) in the S&P 500. The VIX typically spikes when stocks decline and falls in a steadily rising market. And right now traders are not betting that things will stay quiet.
    The cost of bets on a quiet market — used either as hedges by traders who expect volatility or as directional wagers o
  • The hottest investment strategy on the planet makes hitting earnings more crucial than ever

    Falling short during earnings season is never good news for a company. But the miss can be even more painful if the firm has passive investors battening down the hatches.
    Over the past seven quarters, stocks with high passive ownership that missed on both earnings and revenue have lagged those with low passive exposure by 1.5 percentage points the following day, according to data compiled by Bank of America Merrill Lynch. And that gap has only widened over time.
    With a smaller proportion of shar
  • President Trump put Tim Cook in an awkward spot on Apple's earnings call

    In general, it can sometimes be hard to know what President Trump is talking about. But when he makes off-the-cuff comments that have implications for investors, we're forced to try to decipher our Tweeter in Chief's words. Last week in an interview with The Wall Street Journal, Trump said that Apple CEO Tim Cook had "promised" to build "three big plants, beautiful plants." "Big, big, big," Trump added.
    It was a bizarre assertion, and one that Apple probably didn't appreciate. Not only beca
  • Advertisement

  • Wall Street is at war with itself over the future of stocks

    JPMorgan strategists Marko Kolanovic and Dubravko Lakos-Bujas have some varying views on the future of the stock market.
    It's a microcosm of the split that is emerging on Wall Street, with some experts — from strategists to hedge fund managers — sounding the alarm over unsustainable market conditions.
    Wall Street equity strategists, on the other hand, still see stocks climbing into year-end.
    JPMorgan is a house divided ... by the stock market, that is.
    In one corner stands
  • Wall Street is sending huge warning signs for stocks

    To a growing chorus of strategists and investors across Wall Street, the stock market looks like it's headed for a rude awakening.
    Their mounting pessimism comes at a time when US equities are looking healthy, at least on the surface. Major indexes are hovering near record highs they reached this past week, while corporate earnings are growing at a blistering pace.
    Yet some market experts think this apparent strength is just masking deeper problems brewing under the surface.
    Count Marko Kolanovi
  • A hot strategy at Two Sigma, one of the hedge fund industry's fastest-growing funds, has made almost no money this year

    A strategy run by $30 billion Two Sigma, an increasingly popular hedge fund, has made almost no money this year.
    Another of Two Sigma's funds has lost nearly 4%.
    Investors, like public pensions, have poured money into Two Sigma and similar quant firms over the past several years.
    A strategy run by $30 billion Two Sigma Investments, one of the hedge fund industry's fastest growing firms, has made almost no money this year, according to a private client letter reviewed by
  • Bitcoin might split again — here's what you need to know

    Bitcoin power brokers were unable to come behind a single solution that would have preserved a unified cryptocurrency by Tuesday morning's deadline.
    As such, the digital currency has officially forked and split in two: bitcoin cash and bitcoin.
    Bitcoin cash is a fork of the bitcoin system: It's a new software that has all the history of the old platform, but instead of 1-megabyte blocks, it will have 8-megabyte blocks.
    Miners have been able to mine for bitcoin cash since Tuesday morning, but the
  • Advertisement

  • GOLDMAN SACHS: There's an overlooked way to make a fortune this earnings season

    Sure, US stocks have edged higher since the start of earnings season, but you could be making even more money.
    All you have to do is identify good companies that have fallen on hard times, position yourself to capture their earnings move, then get the heck out of dodge.
    Sounds straightforward, right? Perhaps, but investors haven't been taking advantage of it. If they were, the trade wouldn't be outperforming to the extent it is.
    A strategy of buying bullish options on stocks that have lagged the
  • There's a morsel of good news about inequality that's buried in all the scary headlines

    Global inequality trends reveal divergence between rich and poor nations
    Rich country middle classes have taken a big hit in recent years
    Millions lifted from poverty in emerging world, especially China
    Income inequality is rising. It is also falling. It all depends on your search parameters.
    That is, inequality has been rising sharply in rich nations, with the middle-class taking a big hit, even as millions of  poor residents in the developing world have edged their way into their own cou
  • The life of 'Pharma bro' Martin Shkreli, who was convicted of securities fraud and faces up to 20 years in prison

    Martin Shkreli, a former pharmaceutical CEO, was found guilty of securities fraud on Friday — but that was hardly the first time he's been in the news.
    Shkreli has been a controversial figure in the public eye ever since he hiked costs of Daraprim, an AIDS treatment drug that has no generic option, from $13.50 to $750 per pill overnight in 2015.
    The move was met with widespread criticism, including from both then-presidential candidates Hillary Clinton and Donald Trump.
    Here's a look at Ma
  • Trump and Yellen could derail the stock market's hottest trade

    Investors in red-hot tech companies are heavily exposed to political risk, and they may not even realize it.
    After all, one of the main selling points for tech stocks last year was how disconnected they were from macro drivers. Traders shied away from energy because they were puzzled by oil, and stayed away from financials and utility stocks because of uncertainty around interest rates. This led to investment funds crowding into tech stocks, for lack of better options.
    But now, in an ironic twis
  • There's been no Trump boost in the US jobs market

    President Donald Trump took the time to trumpet Friday's jobs report numbers on Twitter.
    Trump called the addition of 209,000 workers in July "Excellent Jobs Numbers" and said the job gains were only beginning, claiming deregulation undertaken by his administration will help boost the labor market.
    The thing is, the job gains seen since Trump's inauguration are similar to the trend that began years ago. The jobs report numbers that came in over the first seven months of Trump's pr

Follow @sales_mrktinguk on Twitter!